TFF3 mediates the NF‐κB/COX2 pathway to regulate PMN‐MDSCs activation and protect against necrotizing enterocolitis
Jingping Liu, Qiong Yang, Ziyang Chen, Shuaijun Lv, Jian Tang, Zhe Xing, Mengyu Shi, Aihua Lei, Gang Xiao, Yumei He
Abstract
Abstract Intestinal trefoil factor 3 (TFF3) plays an important role in repairing the intestinal mucosa. However, the detailed mechanism regarding immune regulation by TFF3 is not well defined. Here, we reported that treatment of mouse BM cells and human peripheral blood mononuclear cells from healthy volunteers with TFF3 activated polymorphnuclear myeloid‐derived suppressor cells (PMN‐MDSCs) in vitro. We also found that prostaglandin E2 is a major TFF3‐mediated MDSC target, and that NF‐κB/COX2 signaling was involved in this process. Moreover, TFF3 treatment or transfer of TFF3‐derived PMN‐MDSCs (TFF3‐MDSCs) to experimental necrotizing enterocolitis (NEC) mice caused PMN‐MDSC accumulation in the lamina propria (LP), which was associated with decreased intestinal inflammation, permeability, bacterial loading, and prolonged survival. Interestingly, no NEC severity remission was observed in Rag1 KO mice that were given TFF3‐MDSCs, but coinjection with CD4 + T cells significantly relieved NEC inflammation. Overall, TFF3 mediates the NF‐κB/COX2 pathway to regulate PMN‐MDSC activation and attenuates NEC in a T‐cell‐dependent manner, which suggests a novel mechanism in preventing NEC occurrence.